¼¼°èÀÇ ¿þ¾î·¯ºí ½Å°æÀÚ±Ø ±â±â ½ÃÀå º¸°í¼­(2025³â)
Wearable Neurostimulation Devices Global Market Report 2025
»óǰÄÚµå : 1751176
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,156,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,898,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,640,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¿þ¾î·¯ºí ½Å°æÀÚ±Ø ±â±â ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 13.1%·Î 2029³â±îÁö 11¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ¸¸¼º ÅëÁõÀÇ À¯º´·ü Áõ°¡, ºñħ½ÀÀû Ä¡·á¹ýÀÇ Ã¤Åà Áõ°¡, ÀçÅÃÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Á¤½Å°Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ½Å°æ Á¶Àý ¿ä¹ý¿¡ ´ëÇÑ Àνİú ¼ö¿ë¼º Áõ°¡¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â±âÀÇ ¼ÒÇüÈ­, ¸ÂÃãÇü Ä¡·á¸¦ À§ÇÑ ÀΰøÁö´É ÅëÇÕ, ¹«¼± ¹× ºí·çÅõ½º Áö¿ø ±â¼ú °³¹ß, À¯¿¬Çϰí ÇǺΠģȭÀûÀÎ ¼ÒÀçÀÇ »ç¿ë, »ç¿ëÀÚ Á¦¾î ¹× °Ç°­ ÃßÀûÀ» °­È­Çϱâ À§ÇÑ ¸ð¹ÙÀÏ ¾Û°ú ±â±âÀÇ ÅëÇÕ µîÀÌ ÀÖ½À´Ï´Ù.

½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¿þ¾î·¯ºí ½Å°æÀÚ±Ø ±â±â ½ÃÀåÀÇ Å« ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½Å°æÁúȯÀº ³ú, ô¼ö, ½Å°æ°è¿¡ ¿µÇâÀ» ¹ÌÃÄ ÀÎÁöÀå¾Ö, ¿îµ¿Àå¾Ö, °¨°¢Àå¾Ö µîÀÇ Áõ»óÀ» À¯¹ßÇÏ´Â ÁúȯÀÔ´Ï´Ù. ³ëÈ­´Â ³úÀÇ °¡¼Ò¼º ÀúÇÏ, »êÈ­ ½ºÆ®·¹½º Áõ°¡, ½Å°æ¼¼Æ÷ ±â´É ÀúÇÏ µîÀ» À¯¹ßÇÏ¿© ½Å°æÁúȯÀÇ À§ÇèÀ» ³ôÀ̱⠶§¹®ÀÔ´Ï´Ù. ¿þ¾î·¯ºí ½Å°æÀÚ±Ø ±â±â´Â ÀÌ·¯ÇÑ Àå¾ÖÀÇ ÀÏ»óÀûÀÎ °ü¸®¸¦ Áö¿øÇÏ´Â ºñħ½ÀÀû Ä¡·á ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â Ç¥ÀûÈ­µÈ ÀÚ±ØÀ» Á¦°øÇÔÀ¸·Î½á Áõ»óÀ» ¿ÏÈ­Çϰí, ȯÀÚÀÇ Æí¾ÈÇÔÀ» ³ôÀ̰í, »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 7¿ù ¿µ±¹ ±¹¸³º¸°Ç¿øÀº 2024³â 6¿ù¿¡ 48¸¸ 7,432¸íÀÌ Ä¡¸Å Áø´ÜÀ» ¹Þ¾ÒÀ¸¸ç, 2024³â 5¿ù¿¡ ºñÇØ 3,155¸íÀÌ Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌó·³ ½Å°æÁúȯÀÇ Áõ°¡°¡ ¿þ¾î·¯ºí ½Å°æÀڱر⠽ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¿þ¾î·¯ºí ½Å°æÀÚ±Ø ±â±â ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ¼ö¸éÀÇ ÁúÀ» °³¼±ÇÏ°í ¼ö¸é °ü·Ã ÁúȯÀ» °ü¸®Çϱâ À§ÇØ ¼ö¸é ¿Âµð¸Çµå Çìµå¹êµå¿Í °°Àº Çõ½ÅÀûÀÎ Á¦Ç°À» Ãâ½ÃÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çìµå¹êµå´Â ½Å°æ Àڱذú Æí¾ÈÇÑ °¨°¢ ÀÔ·Â(À½¼º, Áøµ¿ µî)À» ÀÌ¿ëÇÏ¿© »ç¿ëÀÚ°¡ ´õ »¡¸® Àáµé ¼ö ÀÖµµ·Ï µ½°í, ¼ö¸é°ú °ü·ÃµÈ ³úÆÄ ÆÐÅÏÀ» Áõ°¡½ÃÄÑ ÀÌ¿ÏÀ» µ½½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 6¿ù ¹Ì±¹ÀÇ ´º·ÎÅ×Å©³î·¯Áö ±â¾÷ Elemind Technologies Inc.´Â ÁÖ¹®Çü ¼ö¸é¿ëÀ¸·Î ¼³°èµÈ ¼¼°è ÃÖÃÊÀÇ ½Å°æ ÀÚ±Ø ÀåÄ¡ÀÎ Elemind Headband¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Çìµå¹êµå´Â °æµÎ°³ Á÷·ù Àü·ù ÀÚ±Ø(tDCS) µîÀÇ ±â¼úÀ» ÀÌ¿ëÇØ ³ú Ȱµ¿À» Á¶ÀýÇÕ´Ï´Ù. µÎÇÇ¿¡ ÀåÂøµÈ Àü±ØÀ» ÅëÇØ ºÎµå·¯¿î Àü·ù¸¦ Èê·Áº¸³»¾î ÀÌ¿Ï ¹× ÀÎÁö±â´É°ú °ü·ÃµÈ ƯÁ¤ ³ú ºÎÀ§¸¦ ÀÚ±ØÇÕ´Ï´Ù. ÀÌ Çõ½ÅÀº ¼±ÅÃÇÑ ¸ðµå¿¡ µû¶ó Á¤½ÅÀÇ ¸í·á¼ºÀ» Çâ»ó½Ã۰í, ½ºÆ®·¹½º¸¦ ÁÙÀ̰í, ¼ö¸éÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Wearable neurostimulation devices are portable electronic devices designed to deliver targeted electrical stimulation to the brain or nervous system. These devices aim to modulate brain activity to improve cognitive function, manage pain, or treat neurological conditions such as depression, anxiety, and chronic pain. They are typically used for at-home therapy with minimal supervision.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main product types in the wearable neurostimulation devices market include electroencephalography (EEG) devices, transcranial magnetic stimulation (TMS) devices, brain-computer interface (BCI) devices, neurostimulation devices, and cognitive training devices. Electroencephalography (EEG) devices are medical or research tools that monitor brain activity by recording voltage fluctuations resulting from ionic current flows within neurons. These devices are used in various applications, including stroke, spinal cord injury, and cerebral palsy, among others. The key end-users of these devices include rehabilitation centers, hospitals, clinics, and other healthcare facilities.

The wearable neurostimulation devices market research report is one of a series of new reports from The Business Research Company that provides wearable neurostimulation devices market statistics, including wearable neurostimulation devices industry global market size, regional shares, competitors with a wearable neurostimulation devices market share, detailed wearable neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the wearable neurostimulation devices industry. This wearable neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The wearable neurostimulation devices market size has grown rapidly in recent years. It will grow from$0.59 billion in 2024 to $0.67 billion in 2025 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to the rising prevalence of epilepsy and chronic pain, the rising prevalence of mental health disorders, the growing aging population, the increasing number of clinical trials and the increasing prevalence of depression and mental disorders.

The wearable neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to$1.10 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to the increasing prevalence of chronic pain, rising adoption of non-invasive therapies, growing demand for at-home healthcare solutions, heightened mental health awareness, a growing geriatric population, and increasing awareness and acceptance of neuromodulation therapies. Key trends expected during this period include advancements in the miniaturization of devices, the integration of artificial intelligence for personalized treatment, the development of wireless and Bluetooth-enabled technologies, the use of flexible and skin-friendly materials, and the integration of devices with mobile apps for enhanced user control and health tracking.

The rising prevalence of neurological disorders is expected to drive significant growth in the wearable neurostimulation devices market. Neurological disorders are conditions that impact the brain, spinal cord, and nervous system, leading to symptoms such as cognitive, motor, and sensory impairments. This growing prevalence is largely attributed to the aging global population, as aging contributes to reduced brain plasticity, increased oxidative stress, and declining neuronal function, all of which elevate the risk of neurological conditions. Wearable neurostimulation devices offer a non-invasive therapeutic option that supports the daily management of these disorders. By delivering targeted stimulation, these devices help alleviate symptoms, enhance patient comfort, and improve quality of life. For example, in July 2024, the UK's National Health Service reported that 487,432 individuals were diagnosed with dementia in June 2024 an increase of 3,155 cases from May 2024. Thus, the rising number of neurological disorders is propelling the growth of the wearable neurostimulation devices market.

Key players in the wearable neurostimulation devices market are focusing on launching innovative products, such as sleep-on-demand headbands, to improve sleep quality and manage sleep-related conditions. These headbands use neurostimulation or soothing sensory input (like audio or vibration) to help users fall asleep faster and support relaxation by enhancing brainwave patterns associated with sleep. For instance, in June 2024, Elemind Technologies Inc., a US-based neurotechnology company, introduced the Elemind Headband a first-of-its-kind neurostimulation device designed for sleep-on-demand use. The headband utilizes technologies such as transcranial direct current stimulation (tDCS) to modulate brain activity. It applies gentle electrical currents through electrodes placed on the scalp, stimulating specific brain regions associated with relaxation or cognitive function. This innovation helps improve mental clarity, reduce stress, and enhance sleep quality, depending on the selected mode.

In September 2023, Amber Therapeutics, a UK-based neuromodulation therapy provider, acquired Bioinduction for an undisclosed amount. This strategic acquisition grants Amber access to advanced hardware, technical expertise, and manufacturing capabilities, allowing the company to accelerate the development and commercialization of its Amber-UI system. Bioinduction, also based in the UK, specializes in the production of wearable neurostimulation devices, and its integration into Amber's operations marks a key step in scaling next-generation neuromodulation solutions.

Major players in the wearable neurostimulation devices market are Abbott Laboratories, Medtronic plc, FocusCalm, Boston Scientific Corporation, Alten Calsoft Labs India Private Limited, Nihon Kohden Corporation, LivaNova plc, Nevro Corp., Minnetronix Medical Inc., Neuropace Inc., Nalu Medical, Cala Health Inc., Myomo Inc., Ekso Bionics Holdings Inc., Cognito Therapeutics Inc., Apollo Neuroscience Inc., Curonix LLC, Soterix Medical Inc., Theranica Bioelectronics Ltd., NeuroMetrix Inc., Spark Biomedical Inc., Helius Medical Technologies Inc., Hapbee Technologies Inc., Flow Neuroscience, AxioBionics LLC, tVNS Technologies GmbH, Wearable Devices Ltd., and Cadence Biomedical.

North America was the largest region in the wearable neurostimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in wearable neurostimulation devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the wearable neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The wearable neurostimulation devices market consists of revenues earned by entities by providing services such as device sales, maintenance and support, data analytics, therapy customization, remote monitoring, patient education and subscription-based health management. The market value includes the value of related goods sold by the service provider or included within the service offering. The wearable neurostimulation devices market also includes sales of cranial electrotherapy stimulation (CES) devices, vagus nerve stimulation (VNS) devices, spinal cord stimulation (SCS) devices, functional electrical stimulation (FES) devices, peripheral nerve stimulation (PNS) devices and deep brain stimulation (DBS) devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Wearable Neurostimulation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on wearable neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for wearable neurostimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The wearable neurostimulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Wearable Neurostimulation Devices Market Characteristics

3. Wearable Neurostimulation Devices Market Trends And Strategies

4. Wearable Neurostimulation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Wearable Neurostimulation Devices Growth Analysis And Strategic Analysis Framework

6. Wearable Neurostimulation Devices Market Segmentation

7. Wearable Neurostimulation Devices Market Regional And Country Analysis

8. Asia-Pacific Wearable Neurostimulation Devices Market

9. China Wearable Neurostimulation Devices Market

10. India Wearable Neurostimulation Devices Market

11. Japan Wearable Neurostimulation Devices Market

12. Australia Wearable Neurostimulation Devices Market

13. Indonesia Wearable Neurostimulation Devices Market

14. South Korea Wearable Neurostimulation Devices Market

15. Western Europe Wearable Neurostimulation Devices Market

16. UK Wearable Neurostimulation Devices Market

17. Germany Wearable Neurostimulation Devices Market

18. France Wearable Neurostimulation Devices Market

19. Italy Wearable Neurostimulation Devices Market

20. Spain Wearable Neurostimulation Devices Market

21. Eastern Europe Wearable Neurostimulation Devices Market

22. Russia Wearable Neurostimulation Devices Market

23. North America Wearable Neurostimulation Devices Market

24. USA Wearable Neurostimulation Devices Market

25. Canada Wearable Neurostimulation Devices Market

26. South America Wearable Neurostimulation Devices Market

27. Brazil Wearable Neurostimulation Devices Market

28. Middle East Wearable Neurostimulation Devices Market

29. Africa Wearable Neurostimulation Devices Market

30. Wearable Neurostimulation Devices Market Competitive Landscape And Company Profiles

31. Wearable Neurostimulation Devices Market Other Major And Innovative Companies

32. Global Wearable Neurostimulation Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Wearable Neurostimulation Devices Market

34. Recent Developments In The Wearable Neurostimulation Devices Market

35. Wearable Neurostimulation Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â